BofA thinks Wall Street is underestimating one J&J drug

Bank of America nearly doubled its peak sales estimate for one Johnson & Johnson drug ahead of the company's third-quarter earnings.

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestreet.com)